Neural stem cells improve learning and memory in rats with Alzheimer's disease

Pathobiology

Volumn 75, Issue 3, 2008, Pages 186-194

  Wu, Shuliang ^a   Sasaki, Akira ^a   Yoshimoto, Reiko ^a   Kawahara, Yumi ^a   Manabe, Tomotaka ^a   Kataoka, Katsuko ^b   Asashima, Makoto ^c   Yuge, Louis ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alzheimer's disease; Nerve growth factor; Neural stem cells; Recombination adeno associated virus

Indexed keywords

GREEN FLUORESCENT PROTEIN; NERVE GROWTH FACTOR; OKADAIC ACID;

ADENO ASSOCIATED VIRUS; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; FETUS; GENETIC TRANSDUCTION; LEARNING; MALE; MEMORY; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL TRANSPLANTATION;

ALZHEIMER DISEASE; ANIMALS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; FETUS; GENETIC VECTORS; HUMANS; LEARNING; MALE; NERVE GROWTH FACTOR; NEURONS; OKADAIC ACID; RATS; RECOMBINANT PROTEINS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ANIMALIA; RATTUS;

EID: 48749116491     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000124979     Document Type: Article

References (56)

1. Roberson ED, Mucke L: 100 years and counting: prospects for defeating Alzheimer's disease. Science 2006;3:781-784.
2. Alloul K, Sauriol L, Kennedy W, Laurier C, Tessier G, Novosel S, Contandriopoulos A: Alzheimer's disease: a review of the disease, its epidemiology and economic impact. Arch Gerontol Geriatr 1998;27:189-221.
3. Yankner BA: Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996;16:921-932.
4. Caselli RT, Beach TG, Yaari R, Reima EM: Alzheimer's disease a century later. J Clin Psychiatry 2006;11:1784-1800.
5. Turner RS: Alzheimer's disease. Semin Neurol 2006;26:499-506.
6. Selkoe DJ: Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001;81:741-766.
7. Dahm R: Alzheimer's discovery. Curr Biol 2006;16:R906-R910.
8. LeBlanc AC: The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. Curr Alzheimer Res 2005;2:389-402.
9. Glenner GG, Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-890.
10. Olesen OF: Tau, amyloid and Alzheimer's disease. Ugeskr Laeger 1994;156:1116-1117, 1121-1124.
11. Pastorino L, Lu KP: Pathogenic mechanisms in Alzheimer's disease. Eur J Pharmacol 2006;545:29-38.
12. Billingsley ML, Kincaid RL: Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 1997;323:577-591.
13. Ruben GC, Wang JZ, Iqbal K: Paired helical filaments (PHFs) are a family of single filament structures with a common helical turn period:negatively stained PHF imaged by TEM and measured before and after sonication, deglycosylation, and dephosphorylation. Microsc Res Tech 2005;67:175-195.
14. Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B: Histopathological criteria for progressive dementia disorders: clinicopathological correlation and classification by multivariate data analysis. Acta Neuropathol 1987;74:209-225.
15. Dessi F, Colle MA, Hauw JJ, Duyckaerts C: Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease. Rev Prat 1998;48:1873-1878.
16. Gomez-Ramos A, Diaz-Hernandez M, Cuadros R, Hernandez F, Avila J: Extracellular tau is toxic to neuronal cells. FEBS Lett 2006;580:4842-4850.
17. Komblum HI: Introduction to neural stem cells. Stroke 2007;38:810-816.
18. Park KI, Himes BT, Stieg PE, Tessler A, Fischer I, Snyder EY: Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol 2006;199:179-190.
19. Westerlund U, Moe MC, Varghese M, Berg-Johnsen J, Ohlsson M, Langmoen IA, Svensson M: Stem cells from the adult human brain develop into functional neurons in culture. Exp Cell Res 2003;289:378-383.
20. Jordan JD, Ming GL, Song H: Adult neurogenesis as a potential therapy for neurodegenerative diseases. Discov Med 2006;6:144-147.
21. Reubinoff BE, Itsykson P, Turetsky T, Pera MF, Reinhartz E, Itzik A, Ben-Hur T: Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001;19:1134-1140.
22. Martínez-Serrano A, Fischer W, Söderström S, Ebendal T, Björklund A: Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor (NGF) gene transfer to the rat basal forebrain. Proc Natl Acad Sci USA 1996;93:6355-6360.
23. Lin LF, Doherty D, Lile J, Bektesh S, Collins F: GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993;260:1130-1132.
24. Dunnett SB, Rosser AF: Stem cell transplantation for Huntington's disease. Exp Neurol 2007;203:279-292.
25. Kusano K, Tsutsumi Y, Dean J, Gavin M, Ma H, Silver M, Thorne T, Zhu Y, Losordo DW, Aikawa R: Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction. J Mol Cell Cardiol 2007;42:390-399.
26. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 4. San Diego, Academic Press, 1998.
27. Morris R: Development of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11:47-60.
28. Dickson DW, Wertkin A, Mattiace LA, Fier E, Kress Y, Davies P, Yen SH: Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease. Acta Neuropathol 1990;79:486-493.
29. Carson F, Freida L: Histotechnology: A Self-Instructional Text. Chicago, American Society for Clinical Pathology, 1990, pp 167-169.
30. Harris KA, Oyler GA, Doolittle GM, Vincent I, Lehman RA, Kincaid RL, Billingsley ML: Okadaic acid induces hyperphosphorylated forms of tau protein in human brain slices. Ann Neurol 1993;33:77-87.
31. Merrick SE, Trojanowski JQ, Lee VY: Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J Neurosci 1997;17:5726-5737.
32. Harotunia V, Davies P, Vianna C, Buxbaum JD, Purohit DP: Tau protein abnormalities associated with the progression of Alzheimer disease type dementia. Neurobiol Aging 2007;28:1-7.
33. Koss DJ, Hindley KP, Riedel G, Platt B: Modulation of hippocampal calcium signalling and plasticity by serine/threonine protein phosphatases. J Neurochem 2007;102:1009-1023.
34. Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM-Y: PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 2001;168:402-412.
35. Ha DH, Robertson RT, Roshanaei M, Weiss JH: Enhanced survival and morphological features of basal forebrain cholinergic neurons in vitro: role of neurotrophins and other potential cortically derived cholinergic trophic factors. J Comp Neurol 1999;406:156-170.
36. Heese K, Low JW, Inoue H: Nerve growth factor, neural stem cells and Alzheimer's disease. Neurosignals 2006-2007;15:1-12.
37. Genciarelli C, Budoni M, Mercanti D, Fernandez E, Pallini R, Aloe L, Cimino V, Maira G, Casalbore P: In vitro analysis of mouse neural stem cells genetically modified to stably express human NGF by a novel multigenic viral expression system. Neurol Res 2006;28:505-512.
38. Ebert AD, Svendsen CN: A new tool in the battle against Alzheimer's disease and aging: ex vivo gene therapy. Rejuvenation Res 2005;8:131-134.
39. Tuszynski MH: Growth-factor gene therapy for neurodegenerative disorders. Lancet Neurol 2002;1:51-57.
40. Smith DE, Roberts J, Gage FH, Tuszynski MH: Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc Natl Acad Sci USA 1999;96:10893-10898.
41. Tuszynski MH, Roberts J, Senut MC, Gage FH: Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther 1996;3:305-314.
42. Oliveira AA Jr, Hodges HM: Alzheimer's disease and neural transplantation as prospective cell therapy. Curr Alzheimer Res 2005;2:79-95.
43. Pluchino S, Zanotti L, Deleidi M, Martino G: Neural stem cells and their use as therapeutic tool in neurological disorders. Brain Res Rev 2005;48:211-219.
44. Reimers D, Lopez-Toledano MA, Mason I, Cuevas P, Redondo C, Herranz AS, Lobo MV, Bazan E: Developmental expression of fibroblast growth factor (FGF) receptors in neural stem cell progeny: modulation of neuronal and glial lineages by basic FGF treatment. Neurol Res 2001;23:612-621.
45. Jori FP, Galderisi U, Piegari E, Cipollaro M, Cascino A, Pelaso G, Cotrufo R, Giordano A, Melore MA: EGF-responsive rat neural stem cells: molecular follow-up of neuron and astrocyte differentiation in vitro. J Cell Physiol 2003;195:220-233.
46. Hardy J, Allsop D: Amyloid deposition as the central event in the etiology of Alzheimer's disease. Trends Pharmacol Sci 1991;12:383-388.
47. Oddo S, Vasilevko V, Caccamo A, Kitazawa M, Cribbs DH, LaFerla FM: Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 2006;281:39413-39423.
48. Sugaya K, Alvarez A, Marutle A, Kwak YD, Choumkina E: Stem cell strategies for Alzheimer's disease therapy. Panminerva Med 2006;48:87-96.
49. Oliveira AA Jr, Hodges HM: Alzheimer's disease and neural transplantation as prospective cell therapy. Curr Alzheimer Res 2005;2:79-95.
50. Wang Q, Matsumoto Y, Shindo T, Miyake K, Shindo A, Kawanishi M, Kawai N, Tamiya T, Nagao S: Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease. J Med Invest 2006;53:61-69.
51. Rossi F, Cattaneo E: Opinion: neural stem cell therapy for neurological diseases: dreams and reality. Nat Rev Neurosci 2002;3:401-409.
52. Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N, Tamura A, Kirino T, Nakafuku M: Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002;110:429-441.
53. Sugaya K, Brannen CL: Stem cell strategies for neuroreplacement therapy in Alzheimer's disease. Med Hypotheses 2001;57:697-700.
54. Williams LR: Exogenous nerve growth factor stimulates choline acetyltransferase activity in aging Fischer 344 male rats. Neurobiol Aging 1991;12:39-46.
55. Salehi A, Delcroix JD, Swaab DF: Alzheimer's disease and NGF signaling. J Neural Transm 2004;111:323-345.
56. Martinez-Serrano A, Björklund A: Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging. Proc Natl Acad Sci USA 1998;95:1858-1863.